Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3258)
All Articles published online
|
Dec 7, 2010 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Farshad S, Alborzi A, Japoni A, Ranjbar R, Hosseini Asl K, Badiee P, Amin Shahidi M, Hosseini M. Antimicrobial susceptibility of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i45/5746.htm |
| Number | Citing Articles |
| 1 |
Negar Souod, Mohammad Kargar, Abbas Doosti, Reza Ranjbar, Meysam Sarshar. Genetic Analysis of cagA and vacA Genes in Helicobacter Pylori Isolates and Their Relationship with Gastroduodenal Diseases in the West of Iran. Iranian Red Crescent Medical Journal 2013; 15(5): 371 doi: 10.5812/ircmj.3732
|
| 2 |
Reza Khashei, Mahintaj Dara, Abdollah Bazargani, Kamran Bagheri Lankarani, Alireza Taghavi, Maryam Moeini, Behzad Dehghani, Maryam Sohrabi. High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates. APMIS 2016; 124(9): 787 doi: 10.1111/apm.12567
|
| 3 |
Leila Shokrzadeh, Masoud Alebouyeh, Tabassom Mirzaei, Nastaran Farzi, Mohammad Reza Zali. Prevalence of Multiple Drug-ResistantHelicobacter pyloriStrains Among Patients with Different Gastric Disorders in Iran. Microbial Drug Resistance 2015; 21(1): 105 doi: 10.1089/mdr.2014.0081
|
| 4 |
Fariborz Mansour-Ghanaei, Zahra Pedarpour, Afshin Shafaghi, Farahnaz Joukar. Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication. Middle East Journal of Digestive Diseases 2017; 9(2): 100 doi: 10.15171/mejdd.2017.58
|
| 5 |
Marjan Mohammadi, Bahareh Attaran, Reza Malekzadeh, David Y. Graham. Furazolidone, an Underutilized Drug for H. pylori Eradication: Lessons from Iran. Digestive Diseases and Sciences 2017; 62(8): 1890 doi: 10.1007/s10620-017-4628-5
|
| 6 |
Amin Talebi Bezmin Abadi, Tarang Taghvaei, Ashraf Mohabbati Mobarez, Beth M. Carpenter, D. Scott Merrell. Frequency of antibiotic resistance in Helicobacter pylori strains isolated from the northern population of Iran. The Journal of Microbiology 2011; 49(6): 987 doi: 10.1007/s12275-011-1170-6
|
| 7 |
Reza Ranjbar, Farid Yadollahi Farsani, Farhad Safarpoor Dehkordi. Phenotypic analysis of antibiotic resistance and genotypic study of the vacA, cagA, iceA, oipA and babA genotypes of the Helicobacter pylori strains isolated from raw milk. Antimicrobial Resistance & Infection Control 2018; 7(1) doi: 10.1186/s13756-018-0409-y
|
| 8 |
Mohammad Sholeh, Farajolah Maleki, Marcela Krutova, Shirin Bavari, Rezvan Golmoradi, Nourkhoda Sadeghifard, Taghi Amiriani, Ebrahim Kouhsari. The increasing antimicrobial resistance of Helicobacter pylori in Iran: A systematic review and meta‐analysis. Helicobacter 2020; 25(5) doi: 10.1111/hel.12730
|
| 9 |
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective. Molecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
|
| 10 |
Mojdeh Hakemi Vala, Shirin Eyvazi, Hossein Goudarzi, Hamid Reza Sarie, Mehrdad Gholami. Evaluation of Clarithromycin Resistance Among Iranian Helicobacter pylori Isolates by E-Test and Real-Time Polymerase Chain Reaction Methods. Jundishapur Journal of Microbiology 2016; 9(5) doi: 10.5812/jjm.29839
|
| 11 |
Farzad Khademi, Amir Hossein Sahebkar, Hamid Vaez, Mohsen Arzanlou, Hadi Peeridogaheh. Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis. Journal of Global Antimicrobial Resistance 2017; 10: 171 doi: 10.1016/j.jgar.2017.05.021
|
| 12 |
Nasrin Mirzaei, Farkhondeh Poursina, Jamshid Faghri, Majid Talebi, Mohammad Reza Khataminezhad, Akbar Hasanzadeh, Hajieh Ghasemian Safaei. Prevalence of Resistance of Helicobacter pylori Strains to Selected Antibiotics in Isfahan, Iran. Jundishapur Journal of Microbiology 2013; 6(5) doi: 10.5812/jjm.6342
|
| 13 |
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. Gastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
|
| 14 |
Amir Majlesi, Masood Sayedin Khorasani, Ali Reza khalilian, Mohammad Mehdi Aslani, Mohammad jaefari, Mohammad Yousef Alikhani. Antibiotic Susceptibility of Helicobacter pylori Clinical Isolates in Hamadan, West of Iran. International Journal of Enteric Pathogens 2013; 1(1): 8 doi: 10.17795/ijep9344
|
| 15 |
Marwa S. Fathi, Runia Fouad EL-Folly, Rania Ahmed Hassan, Mohammed Ezz El-Arab. Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 2013; 14(3): 235 doi: 10.1016/j.ejmhg.2013.03.004
|
| 16 |
Alireza Bakhshipour, Narges Mohsenpour Mohammadi, Seyed Mahdi Hashemi, Mohammad Kazem Momeni. Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection. International Journal of Infection 2021; 8(1) doi: 10.5812/iji.98954
|
| 17 |
Hassan Salmanroghani, Massoud Mirvakili, Mahmud Baghbanian, Roham Salmanroghani, Golshid Sanati, Pouria Yazdian, John Green. Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial. PLOS ONE 2018; 13(6): e0197096 doi: 10.1371/journal.pone.0197096
|
| 18 |
Abolfazl Jafari-Sales, Behboud Jafari, Homeira Khaneshpour, Zahra Sadeghi-Deylamdeh, Afsoon Shariat, Hossein Bannazadeh-Baghi, Rozita Nasiri. Helicobacter pylori: a systematic review of drug resistance in Iran. Reviews and Research in Medical Microbiology 2024; 35(1): 36 doi: 10.1097/MRM.0000000000000340
|
| 19 |
Mahnaz Shahabimehr, Masoud Alebouyeh, Nastaran Farzi, Arash Mahboubi, Reza Taslimi, Mohammad Reza Zali. Resistance Rate and Minimum Inhibitory Concentration of Metronidazole Among Helicobacter pylori Strains in Tehran, Iran. Archives of Clinical Infectious Diseases 2016; 11(2) doi: 10.5812/archcid.34478
|
| 20 |
Mohammad-Hossein Haddadi, Babak Negahdari, Roya Asadolahi, Abdollah Bazargani. Helicobacter pylori antibiotic resistance and correlation with cagA motifs and homB gene. Postgraduate Medicine 2020; 132(6): 512 doi: 10.1080/00325481.2020.1753406
|
| 21 |
Laleh Mahmoudi, Shohreh Farshad, Mehrdad Seddigh, Paria Mahmoudi, Fardad Ejtehadi, Ramin Niknam. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication. Medicine 2016; 95(42): e4410 doi: 10.1097/MD.0000000000004410
|
| 22 |
Atena Abedi Maghami, Amir Emami, Mohammad Reza Fattahi, Jalal Mardaneh, Neda Pirbonyeh, Abdullah Bazargani. Mutations inside Lgt a Lipoprotein sorting enzyme and 23S rRNA as the candidate signatures in the evaluation of H. pylori Metronidazole and Clarithromycin MDR strains. Gene Reports 2024; 36: 101953 doi: 10.1016/j.genrep.2024.101953
|
| 23 |
David Y. Graham, Sun-Young Lee. How to Effectively Use Bismuth Quadruple Therapy. Gastroenterology Clinics of North America 2015; 44(3): 537 doi: 10.1016/j.gtc.2015.05.003
|
| 24 |
Agnes Tving Stauning, Rie Louise Møller Nordestgaard, Tove Havnhøj Frandsen, Leif Percival Andersen. Helicobacter pylori [Working Title]. 2018; doi: 10.5772/intechopen.80662
|
| 25 |
Nastaran Farzi, Sara Sayadi, Leila Shokrzadeh, Tabassom Mirzaei, Homayoun Zojaji, Abbas Yadegar, Masoud Alebouyeh, Mohammad Reza Zali. Analysis and Comparison of the Phylogenetic Diversity Within Helicobacter pylori Isolates from Iranian and Global Populations by Multi-Locus Sequence Typing. Archives of Clinical Infectious Diseases 2019; 14(5) doi: 10.5812/archcid.64171
|